




Diabetes mellitus (DM) is a chronic, progressive disease charac-
terized by hyperglycemia induced by impaired insulin secretion, 
action or both. Regardless of the type of diabetes, it puts patient 
at high risk of tissue, organ and vessel damage. Unfortunately 
the mechanisms of these damages are still not clear [1,2,5,10]. 
Hyperglycemia induced pyoinflammatory processes of soft tissues 
occur in 40% of patients with diabetes and mortality rate remains 
high – 10-15%. Cellular and humoral immunity impairments lead 
to rapid spread of pathogens, nevertheless local signs of inflam-
mation is not present for a long period. Because of this certain 
peculiarity of the disorder it becomes hard to diagnose and begin 
treatment of the disease at an early stage [3,4,8].
The leading factors in formation and progression of pyoinflam-
matory complications of soft tissues in patients with diabetes mel-
litus include: blood clots, vessel wall damage, changes in blood 
hemorheological properties, impairment of lipid peroxidation 
(LPO), antioxidant protection (AOP) and the oxidative modifica-
tion of proteins (OMP) [6,7,9]. It is important to search for new 
methods for restoring the compensatory-adaptive processes, able 
to improve the course of morphogenetic processes in diabetic 
patients with pyoinflammatory complications of soft tissues.
Therefore the objective of our study is to evaluate the efficacy of 
intravenous application of ozone therapy as a treatment option 
for pyoinflammatory complications in patients with diabetes.
Material and methods. In total, 124 patients presenting with 
pyoinflamatory complications of soft tissue and concomitant 
diabetes mellitus were observed. Patients were divided into two 
groups according the treatment method. The study group consisted 
of 53 (42,7%) patients who received an intravenous ozone therapy 
application together with conservstive and surgery treatment 
(antibiotics, infusion therapy, antiplatelet agents, antispasmodics, 
vitamins, insulin and other). The control group consisted of 71 
(57,2%) patients, who were treated only by conventional methods. 
All patients from the study group received intravenous ozone 
saline into the ulnar vein through catheter in complex with 
conservative and surgical treatment. Treatment period was 6-15 
days. Patients from control group received only conservative and 
surgical treatment. 
Pyoinflammatory markers were evaluated 3 times during the 
study period: at the beginning, during and after termination of 
treatment. The list of markers and the way of their evaluation 
are given below. 
The oxidative modification of proteins (OMP) and the products of 
lipid peroxidation (LPO) in plasma was determined by reaction of 
2,4-dinitrophenylhydrazine with the formation of hydrazones of 
characteristic absorption spectrum. The OMP rate was estimated 
by the number of formed aldehyde and ketone groups. LPO was 
determined by reaction with thiobarbituric acid. The method is 
based on the reaction between malondialdehyde (MDA) and 
thiobarbituric acid, which at high temperature and acidic pH 
value proceeds with the formation of colored trimetine complex 
containing one molecule of malondialdehyde and two molecules 
of thiobarbituric acid. The maximum absorption of the complex 
is at 532 nm. MDA content was calculated on the basis of the 
molar extinction coefficient (1,56х105М-1см-1). Ceruloplasmin 
(CP) was determined by the method, based on the oxidation of 
p-phenylenediamine involving ceruloplasmin. Enzymic reaction 
was stopped by adding sodium fluoride. The concentration of 
ceruloplasmin, determined by a modified Revin method, was 
judged upon by optical density value of the formed products. 
To calculate the results, the obtained optical density value was 
multiplied by conversion factor and in such way ceruloplasmin 
concentration rate (in mg/L of serum) was found. It constitutes 
205,4±13,5 mg/liter of serum.
Determination of leukocyte index of intoxication (LII) was evalu-
ated by Y.Y. Khalf-Khalif formula (1941): LII = (4Mn + 3Yn + 
2Bn + Sn)(Pl + 1) / (L + Mn)(e + 1), where: LII- leukocyte index 
of intoxication; Mn – myelocytes number; Yn – young neutro-
phils number; Bn – band neutrophils number; Sn – segmented 
neutrophils number; Pl – plasma cells number; L – lymphocytes; 
Mn – monocytes number; e – eosinophils number. According to 
the author the normal LII value was 1,0±0,5.
Results and their discussion. In total, 124 patients with pyoin-
flammatory complications of soft tissues and diabetes were ob-
served. During the treatment period patients underwent following 
surgical procedures: 33 (26,6%) patients underwent primary de-
bridement; disarticulation of the toes was performed in 37 (29,8%) 
patients: in 11 (8,9%) cases – a big toe, in 10 (8,1%) cases – the 
2nd toe, in 5 (4,0%) cases – a middle toe, in 4 (3,2%) cases – the 
4th toe, in 7 (5,6%) cases – a little toe; opening and draining of 
abscesses of soft tissues occurred in 30 (24,2%) patients. 
The study did not reveal any significant differences in neither 
treatment period between study and control groups according 
the changes in the activity of AOP factor – ceruloplasmin, LPO 
products – malonic aldehyde and OMP (Table 1). 
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Table 1. LPO, OMP and AOP rates in diabetic patients with pyoinflammatory complications (М±m)
Rates













Ceruloplasmin (Е/g of plasma) 5,2±0,10 5,1±0,30 5,1±0,10 5,3±0,30 5,5±0,7 5,5±0,50 >0,05
Malonic aldehyde (mmol/l) 0,23±0,06 0,24±0,05 0,20±0,05 0,22±0,03 0,23±0,05 0,19±0,06 >0,05
OMP rate (∆Е/ml of plasma) 2,2±0,05 2,2±0,04 2,0±0,06 1,5±0,05 1,4±0,03 1,6±0,04 >0,05
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These changes can be considered as favorable biochemical at-
tributes for the application of this treatment in diabetic patients 
with inflammatory complications. 
We evaluated the dynamic of toxicity markers - leukocyte index 
of intoxication (LII), hematological toxicity index (HTI) and 
sorption capacity of red blood cells (SCE) in both study groups. 
Study showed that baseline values of LII did not differ between 
the groups (p>0.05). At the beginning of the treatment mean LII 
in study group patients was 3.6±0.3 (Figure 1). In the same group 
mean LII was 2.9±0.2 on the 7th day, and 1.9±0.1 on the 16th day 
of treatment (r≤0.01). At the beginning of the treatment mean LII 
in control group was 3.6±0.2, 3.7±0.2 on the 7th day and 2.7±0.1 
on the 16th day of treatment (r≤0.01).
Fig. 1. LII dynamics in diabetic patients with pyoinflammatory 
complications of soft tissues
HTI dynamics in patients with pyoinflammatory complications 
and diabetes mellitus are shown in figure 2. Baseline levels of 
HTI did not differ between the groups (p>0.05). Mean baseline 
levels of HTI in the study group was 8.6±0.4 and significantly 
decreased on 7th and 16th days after treatment (mean value was 
4.8±0.4 and 3.5±0.4, respectively; p≤0.01). The trend of mean HTI 
in the control group was 7.9±0.4 at baseline, slightly increased on 
7th day after surgery (reaching 9.0±0.4) and decreased to 5.6±0.3 
on 16th day (p≤0.001). 
Fig. 2. HTI dynamics in patients with puyoinflammatory compli-
cations of soft tissues and diabetes mellitus
Normal values of HTI in healthy individuals is 0,620±0,068. 
Increasing level of HTI indicates the presence of pathological 
process in the body that causes development of intoxication 
syndrome, while decreasing levels indicate the reduction of en-
dogenous intoxication. This index normilizes later than LII, hence 
it is more specific value of endogenous intoxication.
SCE dynamics in patients with pyoinflammatory complications 
and diabetes mellitus are shown in figure 3. In healthy individu-
als red blood cells absorb up to 37.1±1.43% of dye from 0,025% 
methylene blue solution. Mean baseline levels of SCE in study 
group reached 47.3±0.8%. In our study, baseline levels of SCE 
did not differ between the groups (p>0.05).On the 7th day and 16th 
days after treatment SCE decreased to 43.1±0.7% and 39.1±1.0%, 
respectively. Mean baseline level of SCE in the control group 
was 46.9±0.7%; As like LII and HTI, SCE also showed a small 
increase on 7th day and decreased on 16th day after surgery (mean 
values were 47.4±0.6% and 42.1±0.6%, respectively).
Fig. 3. SCE dynamics in patients with pyoinflammatory complica-
tions of soft tissues and diabetes mellitus
Conclusion. Our study demonstrated that implementation of 
ozone therapy in patients with pyoinflammatory complications 
and diabetes mellitus is not accompanied by negative injury 
responses at the level of hemostasis parameters and blood bio-
chemical characteristics. The use of intravenous ozone therapy 
in complex treatment of patients with diabetes and purulent in-
flammation of soft tissues positively effects on the postoperative 
wound healing process. Therefor, ozone therapy can be used in 
addition to conventional therapy in patients with pyoinflammation 
complications of soft tissue and diabetes mellitus. 
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SUMMARY
NEW METHOD OF TREATMENT OF PYOINFLAMMA-
TORY SOFT TISSUE COMPLICATIONS IN PATIENTS 
WITH DIABETES MELLITUS 
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Kozlovskaya I. 
Higher State Educational Institution of Ukraine “Bukovinian 
State Medical University:, Chernivtsi, Ukraine
Our study evaluated the levels of peroxide oxidation of lipids, 
oxidative modification of proteins, antioxidant protection and 
dynamic changes in markers of toxicity in patients with diabetes 
mellitus and purulent-inflammatory complications. In total, 124 
patients were enrolled in the study and were divided into two 
groups according the treatment methods. Study group consisted 
of 53 patients, who received intravenously ozonized saline in 
addition to conservative treatment. The control group consisted 
of 71 patients who received only conventional therapy. The study 
period was 6-15 days. The results showed that the use of ozone 
therapy is not accompanied by negative injury responses at the 
level of hemostasis parameters and blood biochemical character-
istics. Furthermore, ozone therapy may have a favorable effect 
on treatment outcome in patients with purulent-inflammatory 
complications and daibetes mellitus. 
Keywords: diabetes, pyoinflammatory complications, ozone 
therapy, intoxication markers. 
РЕЗЮМЕ
НОВЫЙ МЕТОД ЛЕЧЕНИЯ ГНОЙНО-ВОСПАЛИ-
ТЕЛЬНЫХ ОСЛОЖНЕНИЙ МЯГКИХ ТКАНЕЙ У 
ПАЦИЕНТОВ С САХАРНЫМ ДИАБЕТОМ
Каратеева С.Ю., Плеш И.А., Юркив О.И., 
Семененко С.Б., Козловская И.М.
Высшее государственное учебное заведение Украины «Бу-
ковинский государственный медицинский университет», 
Черновцы, Украина 
Изучена динамика изменений показателей перекисного окис-
ления липидов, окислительной модификации белков, анти-
оксидантной защиты и маркеров интоксикации у больных са-
харным диабетом с гнойно-воспалительными осложнениями. 
В исследовании приняли участия 124 пациента. Пациенты с 
учетом метода лечения были разделены на две группы. Основ-
ную группу составили 53 пациента, которым помимо консер-
вативного и хирургического лечения проводили внутривенное 
введение озонированного физиологического раствора через 
катетер в локтевую вену, курс лечения  6-15 дней. Контроль-
ная группа включала 71 пациента, которые получали только 
традиционное лечение. Результаты исследования показали, 
что применение озонотерапии не сопровождается развитием 
реакций повреждения на уровне параметров гемостаза и био-
химических показателей крови. Авторы статьи, опираясь на 
полученные в результате исследования данные рекомендуют 
применение озонотерапии в комплексном лечении больных 
СД с гнойно-воспалительными осложнениями.
reziume 
rbili qsovilebis Cirqovan-anTebiTi garTule-
bebis mkurnalobis axali meTodi pacientebSi 
Saqriani diabetiT
s. karateeva, i. pleSi, o. iurkovi, s. semenenko, 
i. kozlovskaia
ukrainis umaRlesi saxelmwifo saswavlo daweseb-
uleba “bukovinis saxelmwifo samedicino inuver-
siteti”, Carnovci, ukraina 
kvlevis mizans warmoadgenda rbili qsovilebis 
Cirqovan-anTebiTi garTulebebis ozonoTerapiiT 
mkurnalobis efeqturobis Sefaseba Saqris dia-
betiT avadmyofebSi. 
Seswavlilia lipidebze zeJangis zemoqmedebis, 
cilebis mJaviTi modifikaciis da antioqsidanturi 
dacviTi maCveneblebis da intoqsikaciis markere-
bi Saqriani diabetiT avadmyofebSi Cirqovan-
anTebiTi garTulebebiT. kvlevaSi monawileobda 
124  pacienti. pacientebi mkurnalobis meTodis 
gaTvaliswinebiT gayofili iyo or jgufad: 
ZiriTadi jgufi Seadgina 53 pacientma, romlebsac 
konservatul da qirurgiul mkurnalobasTan 
erTad utardeboda ozonoTerapia, ozonirebuli 
fiziologiuri xsnaris venaSi kaTeteris meS-
veobiT SeyvaniT. sakontrolo jgufi Sedgeboda 
71 pacientisgan, romlebsac Cautarda mxolod 
tradiciuli mkurnaloba.
mkurnalobis Sedegad gamovlinda, rom ozonoTera-
piis gamoyeneba ar iwvevs dazianebiT reaqciebs 
hemostazis da sisxlis bioqimiuri parametrebis 
doneze. miRebul Sedegebze dayrdnobiT avtorebs 
gamotanili aqvT daskvna, Saqriani daibetiT da 
Tanmxlebi Cirqovan-anTebiTi garTulebebiT pa-
cientebSi ozonoTerapiis gamoyenebis mizanSe-
wonilobis Sesaxeb.
